YHO-13351 is an ABCG2 inhibitor, an acrylonitrile derivative, that induces sensitization of cancer stem/initiating-like side population cells to irinotecan.GSK1702934A can be used to study diabetes.
Molecular Weight:
579.73
Purity:
97.88%
CAS Number:
[1346753-00-1]
Formula:
C27H37N3O7S2
Target:
BCRP|||ABC Transporter
T13366
* VAT and and shipping costs not included. Errors and price changes excepted